Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia
Clinical trial NCT02920008 · COMPLETED
Trial details
- NCT number
- NCT02920008
- Sponsor
- Astex Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-16
- Primary completion
- 2020-01-20
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.